Ali Hosseini
Cited by
Cited by
Ligand binding mechanism in steroid receptors: from conserved plasticity to differential evolutionary constraints
K Edman, A Hosseini, MK Bjursell, A Aagaard, L Wissler, A Gunnarsson, ...
Structure 23 (12), 2280-2290, 2015
Identification of dual mTORC1 and mTORC2 inhibitors in melanoma cells: prodigiosin vs. obatoclax
M Espona-Fiedler, V Soto-Cerrato, A Hosseini, JM Lizcano, V Guallar, ...
Biochemical pharmacology 83 (4), 489-496, 2012
Molecular interactions of prodiginines with the BH3 domain of anti-apoptotic Bcl-2 family members
A Hosseini, M Espona-Fiedler, V Soto-Cerrato, R Quesada, ...
PloS one 8 (2), e57562, 2013
Exploration of protein conformational change with PELE and meta-dynamics
BP Cossins, A Hosseini, V Guallar
Journal of Chemical Theory and Computation 8 (3), 959-965, 2012
Computational prediction of HIV-1 resistance to protease inhibitors
A Hosseini, A Alibés, M Noguera-Julian, V Gil, R Paredes, R Soliva, ...
Journal of Chemical Information and Modeling 56 (5), 915-923, 2016
Atomic picture of ligand migration in toluene 4-monooxygenase
A Hosseini, M Brouk, MF Lucas, F Glaser, A Fishman, V Guallar
The Journal of Physical Chemistry B 119 (3), 671-678, 2015
990 Prodigiosin, a New Bcl-2 Homology Domain-3 Mimetic Proapoptotic Drug
M Espona-Fiedler, V Soto-Cerrato, A Hosseini, V Guallar, R Perez-Tomas
european journal of cancer, S239, 2012
The system can't perform the operation now. Try again later.
Articles 1–7